TikTok’s algorithm favors mental health content over many other topics, including politics, cats and Taylor Swift, according to a Washington Post analysis. At first, the mental health-related videos ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Why the challenge of truly representative democracy is so complex. Moon Duchin, who leads the University of Chicago’s Data and Democracy Research Initiative, explores how math can help solve ...

This recursive possibility makes it seem highly unlikely that our universe is the original one, rather than a simulation nested within another simulation," says Dr. Faizal. "This idea was once thought ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Abstract: Distributed adaptive filtering has emerged as a critical methodology across diverse application domains, including wireless sensor networks, distributed signal processing, and intelligent ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

More than 800 U.S. TikTok users shared their data with The Washington Post. We used it to find out why some people become power users, spending hours per day scrolling. Each circle in the chart ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.